Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBNPCannabiphorol

Heptyl (C7) homologue of CBN, very poorly documented: no published binding or pharmacokinetic data.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₃H₃₀O₂

CAS 55824-14-1

Family
Semi-synthetic cannabinoidProvisional classification
Molar mass
338.50 g/mol

Updated on

In plain terms

CBNP is a variant of cannabinol (CBN) whose side chain has seven carbons instead of five. Where products sold under this name come from is unknown: only a related acid form has been detected, tentatively, in cannabis. No study describes its effects in humans.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    CBNP (cannabiphorol) is the heptyl (C7) homologue of cannabinol: the same aromatic benzo[c]chromene nucleus, with a seven-carbon chain instead of five. The suffix « phorol » has denoted the heptyl series since the description of THCP and CBDP (Citti et al., 2019). In cannabis, only the corresponding acid, CBNPA, has been identified, and only putatively by high-resolution mass spectrometry, without isolation (Linciano et al., 2021). ChEMBL links 1983 rat data to this structure: by the oral route, a fall in systolic blood pressure and in spontaneous motor activity (Zaugg and Kyncl). No measurement of affinity for cannabinoid receptors, no pharmacokinetic data and no human study were found. No reliable source documents the origin of products sold under this name either. In France, it falls within the generic class of benzo[c]chromene derivatives in force since June 2024.

    History

    Source
    Origin not established: no reliable source documents its natural occurrence or where products sold under this name come from; only its acid (CBNPA) has been putatively identified in cannabis

    Route of preparation

    Chemical process

    No characterised biosynthesis. CBNP is the heptyl (C7) homologue of cannabinol. Only the corresponding acid, CBNPA, has been putatively identified by high-resolution mass spectrometry in cannabis samples, without isolation (Linciano et al., 2021).

    Classification

    Family, origin and source verification

    Family

    Semi-synthetic cannabinoid › Provisional classification

    Chemistry

    C7 side chain · neutral form

    Natural trace reported

    Only the corresponding acid, cannabinophorolic acid (CBNPA), has been putatively identified by UHPLC-HRMS in Cannabis sativa samples, without isolation or a reference standard (Linciano 2021). No detection of neutral CBNP was found.

    Linciano P et al. The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions. Talanta 2021;235:122704 (new tab)

    Verification

    Checked on 20 October 2026; some points still await human review.

    Wikipedia (English)

    No dedicated article.

    References

    Identifiers

    Names

    Common name
    Cannabiphorol
    IUPAC name
    3-heptyl-6,6,9-trimethylbenzo[c]chromen-1-ol
    Other names
    CBN-C7 · CBN-heptyl

    Identifiers

    Formula
    C₂₃H₃₀O₂
    CAS
    55824-14-1
    InChIKey
    HMHJWPZANYJXHX-UHFFFAOYSA-N
    SMILES
    CCCCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.